Abound Financial’s DexCom DXCM Stock Holding History

Abound Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.1K	Hold	256	–	–	0.01%	187
2025 Q4	$17K	Buy	+256	New	+$16.6K	0.01%	189

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Abound Financial's DXCM Position: Q1 2026 in Review

Abound Financial held its DexCom (DXCM) position steady in Q1 2026 at 256 shares worth $16.1K. The position accounts for 0.01% of the portfolio, ranked #187.

Abound Financial first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $17K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Abound Financial held 256 shares of DexCom worth $16.1K as of Q1 2026.
Abound Financial left its DexCom share count unchanged in Q1 2026.
DexCom made up 0.01% of Abound Financial's portfolio in Q1 2026, its #187 holding.
Abound Financial first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
Abound Financial's DexCom position peaked at $17K in Q4 2025.
956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Abound Financial's 13F filing for Q1 2026, filed 4 May 2026.